Quantitative PCR of string-test collected gastric material: A feasible approach to detect Helicobacter pylori and its resistance against clarithromycin and levofloxacin for susceptibility-guided therapy
Abstract
Abstract Background As the reduced eradication rate of Helicobacter pylori (H. pylori), we introduced string‐test and quantitative PCR (qPCR) for susceptibility‐guided therapy innovatively. The practicality of the string test was evaluated. Methods It was an open‐label, non‐randomized, parallel, single‐center study, in which subjects tested by 13C‐ urea breath test (UBT) and string‐qPCR were enrolled. Based on the results of string‐qPCR, we calculated clarithromycin and levofloxacin resistance rates and gave 13C‐UBT positive patients 14 days susceptibility‐guided bismuth quadruple therapy. In the empirical therapy group, we retrospectively analyzed the treatment results of 13C‐UBT positive patients also treated with bismuth quadruple at Shenzhen Luohu People's Hospital from January 2021 to May 2022. The eradication rate was compared between susceptibility‐guided therapy and empirical therapy groups. Results The diagnosis of H. pylori infection using the string‐qPCR had an overall concordance rate of 95.9% with the 13C‐UBT results. Based on the results of string‐qPCR, the clarithromycin and levofloxacin resistance rates were 26.1% and 31.8%, respectively. The patients who were given 14 days susceptibility‐guided bismuth‐based quadruple therapy achieved a high H. pylori eradication rate of 91.8%. Retrospective analysis of patient treatment data from January 2021 to May 2022 available in the hospital database revealed an overall success rate of 82.3% for those who received…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.